BCL2L1 antibody (AA 60-64)
Quick Overview for BCL2L1 antibody (AA 60-64) (ABIN362598)
Target
See all BCL2L1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 60-64
-
Specificity
- The antibody detects endogenous level of total BCL-XL protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Peptide sequence around AA 60-64 (A-D-S-P-A) derived from human BCL-XL . Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blotting: 1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Alternative Name
- BCL-XL
-
Background
- Potent inhibitor of cell death. Isoform Bcl-X(L) anti-apoptotic activity is inhibited by association with SIVA isoform 1. Inhibits activation of caspases By similarity. Appears to regulate cell death by blocking the voltage-dependent anion channnel (VDAC) by binding to it and preventing the release of the caspase activator, cytochrome c, from the mitochondrial membrane. The Bcl-X(S) isoform promotes apoptosis.
-
Molecular Weight
- 30 kDa
-
NCBI Accession
- NP_612815
-
UniProt
- Q07817
-
Pathways
- Apoptosis, Negative Regulation of intrinsic apoptotic Signaling
Target
-